SCHEMBL22390293

SCHEMBL22390293

COC(=O)/C=C(/C)c1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
RAB9A P51151 5/20 0.47
MAPT P10636 4/20 0.47
NPC1 O15118 4/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
LMNA P02545 3/20 0.46
MAPK1 P28482 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
GPR183 P32249 1/20 0.45
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CYP1A2 P05177 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22390294 1.00 ALDH1A1 (0.47) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL11544143 0.83 SLC6A3 (0.38) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL11544146 0.83 SLC6A3 (0.38) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL9335464 0.83 CA1 (0.53) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL13864069 0.83 TDP1 (0.53) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL3021584 0.83 PDE4A (0.49) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL10353812 0.82 ALDH1A1 (0.44) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL7996438 0.81 SMN1; SMN2 (0.45) RAB9AMAPTNPC1KMT2AMEN1
SCHEMBL10277124 0.81 PTGS1 (0.46) ALDH1A1RAB9AMAPTNPC1KMT2A
SCHEMBL10277127 0.81 PTGS1 (0.46) ALDH1A1RAB9AMAPTNPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261190-B2 Dihydropyrimidine compounds and uses thereof in medicine SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-03-01 US disclosed
US-20200283445-A1 DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2020-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283445-A1 DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE TPMT, DPYD, SLC10A1 ALDH1A1 445/4885RAB9A 4041/4885MAPT 222/4885
US-11261190-B2 Dihydropyrimidine compounds and uses thereof in medicine DPYD, TPMT, SLC10A1 ALDH1A1 354/4885RAB9A 3634/4885MAPT 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.